e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel biomarkers and old parameters in clinical management of lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM)
O. Baranova, L. Novikova, M. Kameneva, A. Speranskaya, I. Dvorakovskaya, V. Zolotnickaya, V. Perleji (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Session:
Novel biomarkers and old parameters in clinical management of lung diseases
Session type:
Poster Discussion
Number:
414
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Baranova, L. Novikova, M. Kameneva, A. Speranskaya, I. Dvorakovskaya, V. Zolotnickaya, V. Perleji (Saint-Petersburg, Russian Federation). Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM). Eur Respir J 2013; 42: Suppl. 57, 414
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD)
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Pulmonary embolism (PE) in amiodarone-induced pulmonary toxicity (AILT)
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients},
Source: Eur Respir J 2012; 40: 630-640
Year: 2012
Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009
A case of pulmonary capillary haemangiomatosis (PCH) diagnosed by lung biopsy
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE)
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Pulmonary embolism in COPD patients
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS)
Source: Eur Respir J 2006; 28: Suppl. 50, 354s
Year: 2006
Cut-off value of D-dimer in diagnosis of pulmonary embolism in patients with chronic obstructive lung disease
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Lymphangioma in patients with pulmonary lymphangioleiomyomatosis – Results of sirolimus treatment
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Pulmonary embolism is more prevalent than deep vein thrombosis in cases of chronic obstructive pulmonary disease and interstitial lung diseases
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Pulmonary hypertension complicating fibrosing mediastinitis
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016
Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease
Source: International Congress 2014 – Sarcoidosis
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept